These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16542711)

  • 1. Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.
    Chegeni R; Kazemi B; Hajifathali A; Pourfathollah A; Lari GR
    Thromb Res; 2007; 119(2):189-93. PubMed ID: 16542711
    [No Abstract]   [Full Text] [Related]  

  • 2. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
    Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I
    Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
    Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?
    Aras O; Hanson NQ; Tsai MY; Key NS
    Thromb Haemost; 2002 Jan; 87(1):173-4. PubMed ID: 11848451
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V Leiden with deep venous thrombosis.
    Gardner J
    Clin Lab Sci; 2003; 16(1):6-9. PubMed ID: 12587652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Arg306 --> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese.
    Shen MC; Lin JS; Tsay W
    Thromb Haemost; 2001 Feb; 85(2):270-3. PubMed ID: 11246546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolic disease: risk factors and laboratory investigation.
    Alhenc-Gelas M; Aiach M; de Moerloose P
    Semin Vasc Med; 2001; 1(1):81-8. PubMed ID: 15199517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenteric vein thrombosis due to factor V Leiden gene mutation.
    Bergenfeldt M; Svensson PJ; Borgström A
    Br J Surg; 1999 Aug; 86(8):1059-62. PubMed ID: 10460643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity.
    Santacroce R; Bossone A; Brancaccio V; Fortina P; Margaglione M
    Thromb Haemost; 2000 Jun; 83(6):963-4. PubMed ID: 10896257
    [No Abstract]   [Full Text] [Related]  

  • 11. APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
    Strandberg K; Stenflo J; Nilsson C; Svensson PJ
    J Thromb Haemost; 2005 Nov; 3(11):2578-80. PubMed ID: 16241958
    [No Abstract]   [Full Text] [Related]  

  • 12. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems.
    Girolami A; Simioni P; Tormene D
    Haematologica; 2000 Mar; 85(3):225-6. PubMed ID: 10702806
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mutation of factor V Leiden and chronic leg edema with chronic venous insufficiency and recurrent thromboses].
    Chanda RA
    Praxis (Bern 1994); 1999 Sep; 88(36):1449-50. PubMed ID: 10500421
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden gene mutation in three South African families.
    Rubinstein R; Bowers D; Novitzky N; Louw I; Jacobs P
    S Afr Med J; 1999 Feb; 89(2):176. PubMed ID: 10191872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adrenal vein thrombosis during pregnancy].
    Schmitt C; Debord MP; Grange C; Ben Cheikh A; Krauth JP; Dupuis O; Golfier F; Raudrant D
    J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):68-71. PubMed ID: 19896780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular risk factors for thrombosis.
    Bertina RM
    Thromb Haemost; 1999 Aug; 82(2):601-9. PubMed ID: 10605757
    [No Abstract]   [Full Text] [Related]  

  • 20. A Thai patient with the mutation of Arg306 of FV gene identical to the Hong Kong but not to the Cambridge type.
    Hiyoshi M; Hashimoto S; Tagawa S; Arnutti P; Prayoonwiwat W; Tatsumi N
    Thromb Haemost; 1999 Nov; 82(5):1553-4. PubMed ID: 10595653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.